EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia–reperfusion

Kongwei Guo, Yanxing Shang, Zhao Wang, Yu Li, Jinliang Chen, Baofeng Zhu, Dongmei Zhang, Jianrong Chen

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Kongwei Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Center, Affiliated Hospital 2 of Nantong University, Nantong 226001, People's Republic of China; Department of Clinical Medicine, Me…. Hauptthemen laut MEDLINE: Brain Ischemia, Ischemic Stroke, Reperfusion Injury. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiangsu Provincial Commission of Health and Family Planning, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BRG1 is a key factor in the process of apoptosis and oxidative damage; however, its role in the pathophysiology of ischemic stroke is unclear. Here, we discovered that during middle cerebral artery occlusion (MCAO) reperfusion in mice, microglia were significantly activated in the cerebral cortex of the infarct area, and BRG1 expression was increased in the mouse MCAO/R model, peaking at 4 days. In microglia subjected to OGD/R, BRG1 expression increased and peaked at 12 h after reoxygenation. After ischemic stroke, in vitro changing the expression of BRG1 expression levels greatly altered the activation of microglia and the production of antioxidant and pro-oxidant proteins. Knocking down BRG1 expression levels in vitro increased the inflammatory response, promoted microglial activation, and decreased the expression of the NRF2/HO-1 signaling pathway after ischemic stroke. In contrast, overexpression of BRG1 dramatically reduced the expression of NRF2/HO-1 signaling pathway and microglial activation. Our research reveals that BRG1 reduces postischemic oxidative damage via the KEAP1-NRF2/HO-1 signaling pathway, protecting against brain ischemia/reperfusion injury. Using BRG1 as a pharmaceutical target to inhibit inflammatory responses to reduce oxidative damage may be a unique way to explore techniques for the treatment of ischemic stroke and other cerebrovascular illnesses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain IschemiaIschemic StrokeReperfusion InjuryAnimalsMiceDisease Models, AnimalInfarction, Middle Cerebral ArteryKelch-Like ECH-Associated Protein 1MicrogliaNF-E2-Related Factor 2Oxidative StressReperfusionSignal TransductionDNA HelicasesNuclear ProteinsTranscription FactorsMembrane ProteinsHeme Oxygenase-1

Stichwörter der Autor:innen

BRG1Cerebral ischemia–reperfusionMicroglia

Substanzen

Kelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Keap1 protein, mouseSmarca4 protein, mouseDNA HelicasesNuclear ProteinsTranscription FactorsHmox1 protein, mouseMembrane ProteinsHeme Oxygenase-1

Autor:innen und Institutionen

  • Medical Research Center, Affiliated Hospital 2 of Nantong University, Nantong 226001, People's Republic of China; Department of Clinical Medicine, Medical College, Nantong University, Nantong 226001, People's Republic o…
  • Medical Research Center, Affiliated Hospital 2 of Nantong University, Nantong 226001, People's Republic of China; Nantong Key Laboratory of Molecular Immunology, Affiliated Hospital 2 of Nantong University, Nantong 2260…
  • Medical Research Center, Affiliated Hospital 2 of Nantong University, Nantong 226001, People's Republic of China; Department of Pathogen Biology, Medical College, Nantong University, Nantong 226001, People's Republic of…
  • Medical Research Center, Affiliated Hospital 2 of Nantong University, Nantong 226001, People's Republic of China; Department of Respiratory Medicine, Affiliated Hospital 2 of Nantong University, Nantong 226001, People's…
  • Medical Research Center, Affiliated Hospital 2 of Nantong University, Nantong 226001, People's Republic of China; Department of Emergency, Affiliated Hospital 2 of Nantong University, Nantong 226001, People's Republic o…

Förderung

  • Jiangsu Provincial Commission of Health and Family Planning
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Guo, K., Shang, Y., Wang, Z., Li, Y., Chen, J., Zhu, B., Zhang, D., & Chen, J. (2023). BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia–reperfusion. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110201

Vancouver

Guo K, Shang Y, Wang Z, Li Y, Chen J, Zhu B, et al. BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia–reperfusion. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110201

BibTeX
@article{Guo2023,
  author = {Guo, Kongwei and Shang, Yanxing and Wang, Zhao and Li, Yu and Chen, Jinliang and Zhu, Baofeng and Zhang, Dongmei and Chen, Jianrong},
  title = {BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia–reperfusion},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110201}
}
Kostenlos starten →